Potential risks of antialergic drugs

Abstract

Among more than 10 thousand diseases, according to the classification of ICD-11, allergies (from greek allos - other and ergon - action) are a very common disease of civilization: in the world more than 20% of the population suffer from allergies, that is, one in five people. Despite some advances in the pharmacovigilance system (official observations of drug safety), adverse reactions of antiallergic drugs still remain one of the reasons for paradoxical situations in pharmacotherapy, especially with their unsustainable use. In this article, the authors drew the attention of pharmacologists, doctors and pharmacists to the potential risks of antiallergic drugs and the rational conditions for their warnings.